Development and comparative pharmacokinetic evaluation of iodine-125- and fluorine-18-labelled analogues of 4-(benzo[ <i>d</i> ]thiazol-2-yl)phenylboronic acid for boron neutron capture therapy

Changkeun Im, Mah Rukh Zia, Iqra Bibi, Kyung Jun Kang, Jung Young Kim, Ho Young Kim, Ji-Ae Park

Open source

DOI: 10.1039/d6ra07719f
Published: 2026
Container: RSC Advances
Publisher: Royal Society of Chemistry (RSC)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1039/d6ra07719f,
  title = {Development and comparative pharmacokinetic evaluation of iodine-125- and fluorine-18-labelled analogues of 4-(benzo[
                    <i>d</i>
                    ]thiazol-2-yl)phenylboronic acid for boron neutron capture therapy},
  author = {Changkeun Im and Mah Rukh Zia and Iqra Bibi and Kyung Jun Kang and Jung Young Kim and Ho Young Kim and Ji-Ae Park},
  year = {2026},
  journal = {RSC Advances},
  doi = {10.1039/d6ra07719f},
  url = {https://doi.org/10.1039/d6ra07719f}
}

RIS

TY  - JOUR
TI  - Development and comparative pharmacokinetic evaluation of iodine-125- and fluorine-18-labelled analogues of 4-(benzo[
                    <i>d</i>
                    ]thiazol-2-yl)phenylboronic acid for boron neutron capture therapy
AU  - Changkeun Im
AU  - Mah Rukh Zia
AU  - Iqra Bibi
AU  - Kyung Jun Kang
AU  - Jung Young Kim
AU  - Ho Young Kim
AU  - Ji-Ae Park
PY  - 2026
JO  - RSC Advances
DO  - 10.1039/d6ra07719f
UR  - https://doi.org/10.1039/d6ra07719f
ER  -

APA

Im, C., Zia, M. R., Bibi, I., Kang, K. J., Kim, J. Y., Kim, H. Y., & Park, J. (2026). Development and comparative pharmacokinetic evaluation of iodine-125- and fluorine-18-labelled analogues of 4-(benzo[ <i>d</i> ]thiazol-2-yl)phenylboronic acid for boron neutron capture therapy. RSC Advances. https://doi.org/10.1039/d6ra07719f

Source records

crossref · retrieved 2026-11-05T11:23:22.751Z